Literature DB >> 25149585

Drawing breath without the command of effectors: the control of respiration following spinal cord injury.

Philippa M Warren1, Basem I Awad2, Warren J Alilain3.   

Abstract

The maintenance of blood gas and pH homeostasis is essential to life. As such breathing, and the mechanisms which control ventilation, must be tightly regulated yet highly plastic and dynamic. However, injury to the spinal cord prevents the medullary areas which control respiration from connecting to respiratory effectors and feedback mechanisms below the level of the lesion. This trauma typically leads to severe and permanent functional deficits in the respiratory motor system. However, endogenous mechanisms of plasticity occur following spinal cord injury to facilitate respiration and help recover pulmonary ventilation. These mechanisms include the activation of spared or latent pathways, endogenous sprouting or synaptogenesis, and the possible formation of new respiratory control centres. Acting in combination, these processes provide a means to facilitate respiratory support following spinal cord trauma. However, they are by no means sufficient to return pulmonary function to pre-injury levels. A major challenge in the study of spinal cord injury is to understand and enhance the systems of endogenous plasticity which arise to facilitate respiration to mediate effective treatments for pulmonary dysfunction.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25149585     DOI: 10.1016/j.resp.2014.08.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  Phrenic motor outputs in response to bronchopulmonary C-fibre activation following chronic cervical spinal cord injury.

Authors:  Kun-Ze Lee
Journal:  J Physiol       Date:  2016-06-03       Impact factor: 5.182

Review 2.  Harnessing the power of cell transplantation to target respiratory dysfunction following spinal cord injury.

Authors:  Brittany A Charsar; Mark W Urban; Angelo C Lepore
Journal:  Exp Neurol       Date:  2016-08-13       Impact factor: 5.330

Review 3.  A Review of Different Stimulation Methods for Functional Reconstruction and Comparison of Respiratory Function after Cervical Spinal Cord Injury.

Authors:  Jiaqi Chang; Dongkai Shen; Yixuan Wang; Na Wang; Ya Liang
Journal:  Appl Bionics Biomech       Date:  2020-09-17       Impact factor: 1.781

4.  Local BDNF Delivery to the Injured Cervical Spinal Cord using an Engineered Hydrogel Enhances Diaphragmatic Respiratory Function.

Authors:  Biswarup Ghosh; Zhicheng Wang; Jia Nong; Mark W Urban; Zhiling Zhang; Victoria A Trovillion; Megan C Wright; Yinghui Zhong; Angelo C Lepore
Journal:  J Neurosci       Date:  2018-06-11       Impact factor: 6.167

5.  Respiratory axon regeneration in the chronically injured spinal cord.

Authors:  Lan Cheng; Armin Sami; Biswarup Ghosh; Hannah J Goudsward; George M Smith; Megan C Wright; Shuxin Li; Angelo C Lepore
Journal:  Neurobiol Dis       Date:  2021-05-08       Impact factor: 7.046

6.  Long-Distance Axon Regeneration Promotes Recovery of Diaphragmatic Respiratory Function after Spinal Cord Injury.

Authors:  Mark W Urban; Biswarup Ghosh; Cole G Block; Laura R Strojny; Brittany A Charsar; Miguel Goulão; Sreeya S Komaravolu; George M Smith; Megan C Wright; Shuxin Li; Angelo C Lepore
Journal:  eNeuro       Date:  2019-09-26

Review 7.  Neuroprotective and Neurorestorative Processes after Spinal Cord Injury: The Case of the Bulbospinal Respiratory Neurons.

Authors:  Anne Kastner; Valéry Matarazzo
Journal:  Neural Plast       Date:  2016-08-03       Impact factor: 3.599

8.  LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury.

Authors:  Lan Cheng; Armin Sami; Biswarup Ghosh; Mark W Urban; Nicolette M Heinsinger; Sophia S Liang; George M Smith; Megan C Wright; Shuxin Li; Angelo C Lepore
Journal:  Neurobiol Dis       Date:  2020-10-28       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.